RORA, a large common fragile site gene, is involved in cellular stress response

Oncogene

Volumn 25, Issue 20, 2006, Pages 2901-2908

  Zhu, Y ^a   McAvoy, S ^a   Kuhn, R ^b   Smith, D I ^a,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mayo Clinic   (United States)

Author keywords

Breast cancer; Common fragile site; RORA; Stress response

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BREAST; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE REARRANGEMENT; GENE SEQUENCE; GENE TARGETING; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MOLECULAR STABILITY; OVARY; PRIORITY JOURNAL; PROSTATE; STRESS;

CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITES; CHROMOSOMES, HUMAN, PAIR 15; GENES, NEOPLASM; GENOMIC INSTABILITY; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; TRANS-ACTIVATORS;

EID: 33646706084     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209314     Document Type: Article

References (48)

1. Arlt MF, Casper AM, Glover TW. (2003). Cytogenet Genome Res 100: 92-100.
2. Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI. (2002). Oncogene 21: 8713-8722.
3. Becker-Andre M, Andre E, DeLamarter JF. (1993). Biochem Biophys Res Commun 194: 1371-1379.
4. Bednarek AK, Keek-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K et al. (2001). Cancer Res 61: 8068-8073.
5. Broussard DR, Lozano MM, Dudley JP. (2004). J Virol 78: 4943-4946.
6. Buttel I, Fechter A, Schwab M. (2004). Ann NY Acad Sci 1028: 14-27.
7. Carlberg C, Hooft van Huijsduijnen R, Staple JK, De-Lamarter JF, Becker-Andre M. (1994). Mol Endocrinol 8: 757-770.
8. Casper AM, Nghiem P, Arlt MF, Glover TW. (2002). Cell 111: 779-789.
9. Chang NS, Doherty J, Ensign A, Lewis J, Heath J, Schultz L et al. (2003). Biochem Pharmacol 66: 1347-1354.
10. Chauvet C, Bois-Joyeux B, Berra E, Pouyssegur J, Danan JL. (2004). Biochem J 384: 79-85.
11. Chauvet C, Bois-Joyeux B, Danan JL. (2002). Biochem J 364: 449-456.
12. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R et al. (1997). Cancer Res 57: 504-512.
13. Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, Mancini R et al. (2001). Proc Natl Acad Sci USA 98: 3346-3351.
14. Dussault I, Giguere V. (1997). Mol Cell Biol 17: 1860-1867.
15. Finnis M, Dayan S, Hobson L, Chenevix-Trench G, Friend K, Ried K et al. (2005). Hum Mol Genet 14: 1341-1349.
16. Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M et al. (1997). Cancer Res 57: 1435-1437.
17. Giguere V. (1999). Endocr Rev 20: 689-725.
18. Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G. (1994). Genes Dev 8: 538-553.
19. Glover TW, Berger C, Coyle J, Echo B. (1984). Hum Genet 67: 136-142.
20. Gopalakrishnan VK, Banerjee AG, Vishwanatha JK. (2003). Pancreatology 3: 293-302.
21. Hamilton BA, Frankel WN, Kerrebrock AW, Hawkins TL, FitzHugh W, Kusumi K et al. (1996). Nature 379: 736-739.
22. He YW, Deftos ML, Ojala EW, Bevan MJ. (1998). Immunity 9: 797-806.
23. Hirose T, Smith RJ, Jetten AM. (1994). Biochem Biophys Res Commun 205: 1976-1983.
24. Huebner K, Garrison PN, Barnes LD, Croce CM. (1998). Annu Rev Genet 32: 7-31.
25. Huebner K, Hadaczek P, Siprashvili Z, Druck T, Croce CM. (1997). Biochim Biophys Acta 1332: M65-M70.
26. Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M et al. (2005). Mol Cancer Res 3: 130-138.
27. Jetten AM. (2004). Curr Drug Targets Inflamm Allergy 3: 395-412.
28. Jetten AM, Ueda E. (2002). Cell Death Differ 9: 1167-1171.
29. Jiang H, Ren Y, Zhao J, Feng J. (2004). Hum Mol Genet 13: 1745-1754.
30. Krummel KA, Denison SR, Calhoun E, Phillips LA, Smith DI. (2002). Genes Chromosomes Cancer 34: 154-167.
31. Laiho M, Latonen L. (2003). Ann Med 35: 391-397.
32. Lau P, Bailey P, Dowhan DH, Muscat GE. (1999). Nucleic Acids Res 27: 411-420.
33. Lee WH, Murphree AL, Benedict WF. (1984). Nature 309: 458-460.
34. Littman DR, Sun Z, Unutmaz D, Sunshine MJ, Petrie HT, Zou YR. (1999). Cold Spring Harb Symp Quant Biol 64: 373-381.
35. Ludes-Meyers JH, Bednarek AK, Popescu NC, Bedford M, Aldaz CM. (2003). Cytogenet Genome Res 100: 101-110.
36. Matsuyama A, Shiraishi T, Trapasso F, Kuroki T, Alder H, Mori M et al. (2003). Proc Natl Acad Sci USA 100: 14988-14993.
37. Matysiak-Scholze U, Nehls M. (1997). Genomics 43: 78-84.
38. Migita H, Satozawa N, Lin JH, Morser J, Kawai K. (2004). FEBS Lett 557: 269-274.
39. Missbach M, Jagher B, Sigg I, Nayeri S, Carlberg C, Wiesenberg I. (1996). J Biol Chem 271: 13515-13522.
40. Moretti RM, Marelli MM, Motta M, Polizzi D, Monestiroli S, Pratesi G et al. (2001). Prostate 46: 327-335.
41. Nau MM, Brooks Jr BJ, Carney DN, Gazdar AF, Battey JF, Sausville EA et al. (1986). Proc Natl Acad Sci USA 83: 1092-1096.
42. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. (2002). Annu Rev Genet 36: 617-656.
43. Pawlikowski M, Kunert-Radek J, Winczyk IC, Melen-Mucha G, Gruszka A, Karasek M. (1999). Adv Exp Med Biol 460: 369-372.
44. Schrader M, Danielsson C, Wiesenberg I, Carlberg C. (1996). J Biol Chem 271: 19732-19736.
45. Smith DI, Huang H, Wang L. (1998). Int J Oncol 12: 187-196.
46. Sutherland GR, Baker E, Richards RI. (1998). Trends Genet 14: 501-506.
47. Sutherland GR, Richards RI. (1995). Curr Opin Genet Dev 5: 323-327.
48. Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N et al. (2004). Genes Chromosomes Cancer 40: 85-96.